Serial Number | 90288318 |
Word Mark | HETLIOZ LQ (TASIMELTEON) |
Filing Date | Thursday, October 29, 2020 |
Status | 700 - REGISTERED |
Status Date | Tuesday, August 23, 2022 |
Registration Number | 6828606 |
Registration Date | Tuesday, August 23, 2022 |
Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, May 11, 2021 |
Description of Mark | The mark consists of the literal elements "Hetlioz LQ" in sans serif font above the literal element "(tasimelteon)", with a series of eleven circles of increasing diameter in an arc from the H to the open parenthesis. |
Goods and Services | Pharmaceutical preparations, in liquid form and containing tasimelteon, for use in the treatment of diseases and disorders of the central nervous system, diseases and disorders having an impact on the central nervous system, diseases and disorders having a central nervous system manifestation, diseases and disorders of the circadian rhythm, diseases and disorders having an impact on circadian rhythm, and diseases and disorders having a circadian rhythm manifestation |
Disclaimer with Predetermined Text | "TASIMELTEON" |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, December 22, 2020 |
Primary Code | 005 |
First Use Anywhere Date | Friday, August 28, 2020 |
First Use In Commerce Date | Tuesday, December 1, 2020 |
Party Name | Vanda Pharmaceuticals Inc. |
Party Type | 30 - Original Registrant |
Legal Entity Type | 03 - Corporation |
Address | Washington, DC 20037 |
Party Name | Vanda Pharmaceuticals Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Washington, DC 20037 |
Party Name | Vanda Pharmaceuticals Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Washington, DC 20037 |
Event Date | Event Description |
Tuesday, August 23, 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
Tuesday, August 23, 2022 | REGISTERED-PRINCIPAL REGISTER |
Thursday, July 21, 2022 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
Wednesday, July 20, 2022 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
Tuesday, June 28, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Monday, June 27, 2022 | STATEMENT OF USE PROCESSING COMPLETE |
Friday, June 17, 2022 | USE AMENDMENT FILED |
Monday, June 27, 2022 | SOU EXTENSION 2 GRANTED |
Friday, June 17, 2022 | SOU EXTENSION 2 FILED |
Monday, June 27, 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Friday, June 17, 2022 | TEAS EXTENSION RECEIVED |
Friday, June 17, 2022 | TEAS STATEMENT OF USE RECEIVED |
Wednesday, December 29, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Monday, December 27, 2021 | SOU EXTENSION 1 GRANTED |
Monday, December 27, 2021 | SOU EXTENSION 1 FILED |
Monday, December 27, 2021 | TEAS EXTENSION RECEIVED |
Tuesday, July 6, 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, May 11, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, May 11, 2021 | PUBLISHED FOR OPPOSITION |
Wednesday, April 21, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Monday, April 5, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Monday, April 5, 2021 | EXAMINER'S AMENDMENT ENTERED |
Monday, April 5, 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Monday, April 5, 2021 | EXAMINERS AMENDMENT E-MAILED |
Monday, April 5, 2021 | EXAMINERS AMENDMENT -WRITTEN |
Tuesday, March 30, 2021 | ASSIGNED TO EXAMINER |
Wednesday, December 23, 2020 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
Tuesday, December 22, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
Monday, November 2, 2020 | NEW APPLICATION ENTERED IN TRAM |